MX2022012219A - Regimen para la aplicacion topica repetida del parche de capsaicina. - Google Patents

Regimen para la aplicacion topica repetida del parche de capsaicina.

Info

Publication number
MX2022012219A
MX2022012219A MX2022012219A MX2022012219A MX2022012219A MX 2022012219 A MX2022012219 A MX 2022012219A MX 2022012219 A MX2022012219 A MX 2022012219A MX 2022012219 A MX2022012219 A MX 2022012219A MX 2022012219 A MX2022012219 A MX 2022012219A
Authority
MX
Mexico
Prior art keywords
regimen
application
capsaicinoid
topical application
capsaicin
Prior art date
Application number
MX2022012219A
Other languages
English (en)
Inventor
Marielle Eerdekens
Sylvia Engelen
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2022012219A publication Critical patent/MX2022012219A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a un régimen para el tratamiento repetido de una afección neuropática, preferentemente dolor neuropático periférico, que comprende una primera aplicación de una o más unidades de dosis tópicas de capsaicinoide y/o capsaicinas de alta concentración, preferentemente parches de capsaicinoide y/o capsaicina de alta concentración, seguido de una segunda aplicación de una o más unidades de dosis tópicas de capsaicinoide y/o capsaicinas de alta concentración, preferentemente parches de capsaicinoide y/o capsaicina de alta concentración, en los que el período de tiempo entre la primera aplicación y la segunda aplicación se acorta preferentemente con el fin de aumentar la tasa de pacientes que responden al tratamiento.
MX2022012219A 2020-04-03 2021-04-06 Regimen para la aplicacion topica repetida del parche de capsaicina. MX2022012219A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20167983 2020-04-03
EP20173155 2020-05-06
PCT/EP2021/058837 WO2021198524A1 (en) 2020-04-03 2021-04-06 Regimen for repeated topical application of capsaicin patch

Publications (1)

Publication Number Publication Date
MX2022012219A true MX2022012219A (es) 2022-10-27

Family

ID=75396804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012219A MX2022012219A (es) 2020-04-03 2021-04-06 Regimen para la aplicacion topica repetida del parche de capsaicina.

Country Status (11)

Country Link
US (1) US20230310351A1 (es)
EP (1) EP4125841A1 (es)
JP (1) JP2023520024A (es)
KR (1) KR20220164022A (es)
CN (1) CN115361941A (es)
AU (1) AU2021249486A1 (es)
BR (1) BR112022020000A2 (es)
CA (1) CA3177175A1 (es)
CL (1) CL2022002708A1 (es)
MX (1) MX2022012219A (es)
WO (1) WO2021198524A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
MXPA05006670A (es) 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
EP2907503A1 (en) 2003-04-10 2015-08-19 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
DK1613297T3 (da) 2003-04-14 2007-09-24 Lohmann Therapie Syst Lts Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin
US20060100272A1 (en) 2004-06-02 2006-05-11 Sri International Formulations for the treatment of pain
US7771760B2 (en) 2005-04-01 2010-08-10 Neurogesx, Inc. Oils of capsaicinoids and methods of making and using the same
CA2854206C (en) 2011-09-09 2018-04-10 Api Genesis, Llc Pain relief compositions, comprising a trpv1 selective agonist, and manufacture and uses thereof
US20140134261A1 (en) * 2012-08-21 2014-05-15 Trinity Laboratories, Inc. Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores
JP6563954B2 (ja) 2014-04-15 2019-08-21 ヴィズリ・ヘルス・サイエンスィズ・エルエルシー 痛みの緩和のための局所組成物、製造および使用

Also Published As

Publication number Publication date
CN115361941A (zh) 2022-11-18
EP4125841A1 (en) 2023-02-08
BR112022020000A2 (pt) 2022-11-22
US20230310351A1 (en) 2023-10-05
WO2021198524A1 (en) 2021-10-07
CL2022002708A1 (es) 2023-05-19
AU2021249486A1 (en) 2022-12-08
CA3177175A1 (en) 2021-10-07
JP2023520024A (ja) 2023-05-15
KR20220164022A (ko) 2022-12-12

Similar Documents

Publication Publication Date Title
MX345460B (es) Dispositivos y metodos para tratamiento de heridas o de la piel.
CO2020000939A2 (es) Formas de dosificación nasal de dihidroergotamina
MX348184B (es) Métodos y composiciones para tratar diarrea asociada con vih.
WO2019067405A3 (en) FORMULATION OF FENFLURAMINE COMPATIBLE WITH A CÉTOGENEOUS REGIMEN
MX2021013354A (es) Metodos para tratar y/o prevenir queratosis actinica.
MX2022005132A (es) Terapia combinada con formulaciones de anticuerpos anti-pvrig y anticuerpos anti-pd-1.
MX2019013862A (es) Terapia de combinacion.
MX2020011817A (es) Metodos para tratar el linfoma.
WO2019157495A3 (en) Methods for preventing and/or treating bone loss conditions by modulating irisin
PH12020551726A1 (en) Treatment of atopic dermatitis
GB2525517A (en) Topical preparation for pain relief
MX2022012219A (es) Regimen para la aplicacion topica repetida del parche de capsaicina.
MX2021004207A (es) Uso de reboxetina para el tratamiento de narcolepsia.
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
MX2021000583A (es) Producto de grafeno y usos terapeuticos del mismo.
MX2022011400A (es) Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento.
PH12020551331A1 (en) Treatment and prevention of pre-eclampsia
MX2018014135A (es) Tratamiento del dolor.
BR112018005602A2 (pt) composição para tratar dor
MX2021006488A (es) Composiciones para mejorar la funcion sexual.
CL2019001918A1 (es) Métodos para tratar infecciones bacterianas.
MX2020002585A (es) Inhibidor de hdac combinado con un modulador del punto de control inmunitario para la terapia contra el cancer.
MX2019006156A (es) Sistema de tratamiento de heridas y metodos de uso y montaje.
MX2022005250A (es) Combinaciones terapeuticas de acalabrutinib y capivasertib para tratar neoplasias malignas de linfocitos b.
MX2016007973A (es) Composicion topica que comprende ingredientes naturales para el alivio de moretones o hematomas en la piel y uso de la misma.